Kit ELISA sandwich TNFRSF6B (DcR3) (human): quantitative determination of Hu DcR3 in serum, plasma or cell culture medium. The test recognizes only the natural and recombinant forms of Hu DcR3.
Accession number
O95407
Dose range
0.328-80 ng/ml
Sensitivity of the dosage
0.3 ng
Calibration range
0.3 ng/ml to 80 ng/ml
Dose
ELISA solid-phase sandwich
Brand
Invitrogen
Kit ELISA sandwich TNFRSF6B (DcR3) (human): quantitative determination of Hu DcR3 in serum, plasma or cell culture medium. The test recognizes only the natural and recombinant forms of Hu DcR3.
Kit ELISA sandwich TNFRSF6B (DcR3) (human): quantitative determination of Hu DcR3 in serum, plasma or cell culture medium. The test recognizes only the natural and recombinant forms of Hu DcR3.
Method principle: This ELISA solid phase sandwich test (immuno-enzymatic dose) measures the amount of target bound between a pair of matched antibodies. A specific target antibody is pre-adsorbed into the wells of the supplied microplate. Samples, standards or controls are added to these wells and bind to immobilized antibodies (capture antibodies). The sandwich is formed by adding the second antibody (detection antibody), then a substrate solution reacts with the enzyme-antibodies-target complex to produce a measurable signal. The intensity of this signal is directly proportional to the concentration of the target present in the original sample.
Rigorous validation: Each batch manufactured from this ELISA kit is checked for criteria such as sensitivity, specificity, accuracy and reproducibility from one batch to another (see the package leaflet for more information on validation).
L-apoptosis is induced by some cytokines, including TNF and Fas ligand in the TNF family, by their receptor-containing death range. Several new members of the TNFR family, including DR3, DR4, DR5 and DR6, have recently been discovered and are functioning as cell death receptors. Two lure receptors, DcR1 and DcR2, have recently been identified to compete with DR4 and DR5 for their TRAIL ligand bond. A new lure receptor was discovered more recently and designated DcR3 and TR6, respectively. Unlike DcR1 and DcR2, DcR3 is a soluble molecule rather than a membrane-associated molecule. DCR3 binds to FasL and LIGHT and inhibits FasL and LIGHT induced apoptosis. The transcription of DCR3 is expressed in a number of lung and colon carcinomas and in some normal tissues.